Search

The data of COVID-19 pandemic when analysed with different probable modulators like affecting social structure like religion, blood group, the burden of other diseases, vaccination for other diseases and many more revealed that Rh -ve blood group, irrespective of ABO blood group may be an important predisposing factor for acquiring SARS-CoV-2 infection and serious disease leading to lethality. Among ABO blood groups, people with blood group A seem to be the most susceptible to COVID-19 followed by AB, O and B blood group. Among different religious groups, Muslim dominated nations had a smaller number of COVID-19 cases and deaths while those dominated by Christians had more devastating COVID-19. The BCG and to some extent Rotavirus vaccinations seem to protect the population from SARS-CoV-2 infection and deaths while other vaccinations like Polio, DPT, HepB, Measles, HiB appeared to support the SARS-CoV-2. The national burden of diseases like TB, HIV-AIDS, Malaria, cardiovascular disorders, natural calamities, fires, food deficiency and poor sanitation seems to protect against SARS-CoV-2 infections and COVID-19. However, the burden of neoplasms (cancers) was significantly increasing the risk of SARS-CoV-2 infections and lethal outcome of COVID-19. The emergence of Omicron variant of SARS-CoV-2 in last two weeks of the year 2021 also had an almost similar association with different disease modulators but gaining more momentum in nations with greater coverage of DPT, HiB, HepB, Polio vaccination and higher burden of neoplasms. This analysis may help in better planning for control of COVID-19 in different societies and nations with reasonable variation in pandemic control strategy instead of a blanket package of practice to curb the disease. The limitations of data-based analysis are also discussed.

The study aimed to investigate the occurrence of carbapenem resistant E. coli and P. aeruginosa in apparently healthy, captive blackbucks and leopards of India. Faecal samples of blackbucks (n = 7) and leopards (n = 7) were processed to isolate carbapenem resistant E. coli (CRE) and P. aeruginosa (CRP). Forty (leopards n = 26; blackbuck n = 14) E. coli and two P. aeruginosa (blackbuck n = 2) samples were isolated from the faecal samples (n = 14). Eleven carbapenem resistant isolates were recovered, of which 10 were CRE and one was CRP. The minimum inhibitory concentration (MIC) was determined for meropenem for carbapenem resistant isolates and was between 8 and 64 μg/mL. All the CRE and CRP were phenotypically multidrug resistant, and six CRE were extended-spectrum beta- lactamases (ESBL) producers. On genotypic screening, seven CRE and one CRP were positive for the blaNDM carbapenemase gene. Efflux pump-mediated carbapenem resistance was noticed in four CRE isolates (36.4%, 4/11). Of the six ESBL producing CRE, four isolates carried blaCTX-M-1 genes. The CRE isolates also harbored blaTEM-1, blaAmpC, qnrA, qnrB, qnrS, tetA, tetB and sul1 resistance genes. On Shiga toxin virulence screening, Stx1, Stx2 genes were detected in two and one isolates, respectively. Plasmid typing of CRE revealed that the blaNDM genes were carried on an Incl1 plasmid. The plasmid multilocus sequence typing (pMLST) of the isolates showed the Sequence Type (ST) 297. The occurrence of carbapenem resistance bacteria in captive wildlife should be a major public health priority., Cilj rada bio je istražiti slučajeve otpornosti bakterija E. coli i P. aeruginosa na karbapenem u zdravih antilopa i leoparda iz zatočeništva u Indiji. Uzorci izmeta antilopa (n = 7) i leoparda (n = 7) obrađeni su kako bi se izolirale bakterije E. coli (CRE) i P. aeruginosa (CRP) otporne na karbapenem. Iz uzoraka izmeta (n = 14) dobiveno je 40 izolata (leopard n = 26, antilopa n = 14) E. coli i 2 izolata P. aeruginosa (antilopa n = 2). Pronađeno je 11 izolata otpornih na karbapenem, od kojih je 10 E. coli i 1 P. aeruginosa. Određena je minimalna inhibicijska koncentracija (MIK) za meropenem za izolate otporne na karbapenem, od 8 za E. coli i 64 μg/mL za P. aeruginosa. Svi izolati E. coli i P. aeruginosa fenotipski su bili otporni na širok spektar lijekova, a 6 izolata E. coli proizvodilo je beta- laktamaze širokog spektra (ESBL). Genotipskim probirom 7 izolata E. coli i 1 izolat P. aeruginosa bili su pozitivni na karbapenemaza gen blaNDM. Otpornost na karbapenem putem efluks pumpe zabilježena je u 4 izolata E. coli (36,4 %, 4/11). Od 6 ESBL producirajućih CRE, 4 izolata nosila su gen blaCTX-M-1. Izolati E. coli također su sadržavali blaTEM-1, blaAmpC, qnrA, qnrB, qnrS, tetA, tetB i sul1 gene otpornosti. Pretragom na šiga-toksin, Stx1 i Stx2 geni utvrđeni su u dva odnosno jednom izolatu. Tipiziranje plazmida CRE otkrilo je prisutnost blaNDM gena na Incl1 plazmidu. Multilokusno tipiziranje sekvencija plazmida (pMLST) izolata otkrilo je sekvenciju tipa (ST) 297. Pojava otpornosti bakterija na karbapenem u divljih životinja iz zatočeništva trebala bi biti javnozdravstveni prioritet.

The fake drug market is estimated at $200 billion by the World Customs Organization (WCO). The World Health Organization estimates that as many as 30% of all medicines sold in some areas of Asia are fake. Of those surveyed, as many as 67% considered counterfeit medicines were labeled dangerous [1]. Indian pharmaceutical companies suggested that in India’s major cities, one in every five strips of medicines sold is a fake leading to an annual revenue loss of 4-5%. It is also estimated that spurious drugs market growth are faster than the real drug market; it has grown from 10% to 20% of the total market.